Medical University of Gdansk clinical trials
Medical University of Gdansk is the lead sponsor of 34 current clinical trials in our Poland and France registers. 15 are recruiting patients now. The most common phase is Not applicable. The drugs named most often in its trials are Apixaban, Aspirin and Carboplatin. The most-studied condition is Manual Therapy.
ClinicalTrials.gov trials by status
Trials by phase
Clinical trials sponsored by Medical University of Gdansk
34 on ClinicalTrials.gov| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
Overnight Dexamethasone in Primary Aldosteronism Screening
NCT06740838 · Primary Aldosteronism, Hypertension
|
Observational | Recruiting | 2024-10 | Poland |
|
Cesarean Scar Defect: a Prospective, Observational Study.
NCT07723157 · ClinicalTrials.gov ↗ · Niche
|
Observational | Recruiting | 2024-10 | Poland |
|
Study of Treatment With Intensified Omeprazole Treatment to Prevent High Output Stoma 1
NCT06917963 · ClinicalTrials.gov ↗ · Stoma - Ileostomy, High Output Stoma, Colon Cancer
|
Not applicable | Recruiting | 2025-04 | Poland |
|
TENS During Transperineal Prostate Biopsy
NCT07578324 · ClinicalTrials.gov ↗ · Prostate Cancer (Diagnosis), Prostate Biopsy, Pain, Procedural
|
Not applicable | Recruiting | 2026-08 | Poland |
|
Shoulder Manipulation in Volleyball Players
NCT06992375 · ClinicalTrials.gov ↗ · Manual Therapy, Manipulation, Muscle Strength
|
Not applicable | Recruiting | 2025-05 | Poland |
|
Assessment of Pulmonary Function in Relation to the Anesthetic Used in Patients Undergoing Bariatric Surgery
NCT06759623 · ClinicalTrials.gov ↗ · Obesity and Obesity-related Medical Conditions
|
Not applicable | Recruiting | 2025-01 | Poland |
|
Risk Factors and Exercise Effects on Abdominal Separation in Seniors
NCT07839572 · ClinicalTrials.gov ↗ · Diastasis Recti Abdominis (DRA), Aging
|
Not applicable | Recruiting | 2026-08 | Poland |
|
Microplastic Analysis in Pediatric Inflammatory Bowel Disease
NCT07141238 · ClinicalTrials.gov ↗ · Crohn Disease, Pediatric Inflammatory Bowel Diseases, Ulcerative Colitis (UC)
|
Observational | Recruiting | 2025-06 | Poland |
|
Individualized Rehabilitation for Osgood-Schlatter or Sever Pain in Youth Athletes
NCT07521280 · ClinicalTrials.gov ↗ · Osgood-Schlatter Disease, Sever's Disease, Apophyseal Pain
|
Not applicable | Recruiting | 2026-04 | Poland |
|
Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCI
NCT04695106 · Atrial Fibrillation, Antithrombotic Therapy, Acute Coronary Syndrome
|
Phase 4 | Recruiting | 2021-10 | Poland |
|
Vitamin D in Dialysis Patients - Diagnostic and Therapeutic Management
NCT06571344 · ClinicalTrials.gov ↗ · Vitamin D Deficiency Due to Chronic Kidney Disease
Drug: Cholecalciferol |
Observational | Recruiting | 2022-11 | Poland |
|
Low-Level Laser Therapy for Osgood-Schlatter or Sever Pain in Youth Athletes
NCT07446517 · Osgood-Schlatter Disease, Sever's Disease
|
Not applicable | Recruiting | 2026-03 | Poland |
|
Psychiatric Status and Symptom Severity in Graft-versus-Host Disease (GvHD).
NCT07314892 · ClinicalTrials.gov ↗ · GVHD, Chronic, GVHD - Graft-Versus-Host Disease, GVHD
|
Observational | Recruiting | 2025-04 | Poland |
|
Active Surveillance vs Adjuvant Chemoradiotherapy for Locally Resected Intermediate-Risk T1 Rectal Cancer
NCT07669298 · ClinicalTrials.gov ↗ · Rectal Cancer
|
Not applicable | Recruiting | 2026-06 | France, Poland |
|
Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic Malignancies
NCT07270263 · Lymphoma, Leukemia, Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma
|
Not applicable | Recruiting | 2024-11 | Poland |
|
Assessment of the Repeatability of Sublingual Microcirculation Function Measurements in Healthy Volunteers and Critically Ill Patients
NCT07397208 · ClinicalTrials.gov ↗ · Critical Illness, Healthy
|
Observational | Not yet open | 2026-02 | Poland |
|
GENECARD - the Use of Genetic, Epigenetic, Metabolomic, Proteomic and Microbiotic Markers, Image and Voice Biomarker Analyses, and Pre- and Intraoperative Clinical Data - to Predict Early Complications After Cardiac Surgery.
NCT07345403 · ClinicalTrials.gov ↗ · Postoperative Delirium (POD), Postoperative Bleeding, Acute Kidney Injury
|
Observational | Not yet open | 2026-01 | Poland |
|
Application Shoulder Manipulation in Volleyball Players
NCT06992388 · ClinicalTrials.gov ↗ · Manual Therapy, Manipulation, Muscles
|
Not applicable | Not yet open | 2025-05 | Poland |
|
Hip Manipulation in Basketball Players
NCT06901089 · ClinicalTrials.gov ↗ · Manual Therapy, Manipulation, Muscles
|
Not applicable | Not yet open | 2025-05 | Poland |
|
Cyclin dEpendent Kinase in tRiple nEGatIVe brEast canceR - a "Window of Opportunity" Study
NCT05067530 · ClinicalTrials.gov ↗ · Triple Negative Breast Neoplasms
|
Phase 2 | Not yet open | 2022-01 | Poland |
|
Eccentric Exercise Rehabilitation After Myocardial Infarction
NCT07729410 · ClinicalTrials.gov ↗ · Myocardial Infarction (MI), Cardiac Rehabilitation
|
Not applicable | Not yet open | 2026-07 | Poland |
|
A Midwife-Led Psychoeducational Intervention to Reduce Pregnancy-Related Anxiety in Low-Risk Pregnant Women
NCT07323459 · ClinicalTrials.gov ↗ · Pregnancy-Related Anxiety (PrA), Fear of Childbirth
|
Not applicable | Not yet open | 2026-01 | Poland |
|
Perfusion Index Variability During Epidural Labor Analgesia
NCT07831967 · ClinicalTrials.gov ↗ · Labor Epidural Analgesia, Perfusion Index, Pain
|
Observational | Not yet open | 2026-09 | Poland |
|
Impact of Appointment Reminder Strategies on Smoking Cessation Clinic Attendance
NCT07779161 · ClinicalTrials.gov ↗ · Behavioral Intervention, Nicotine Addiction
|
Not applicable | Not yet open | 2026-08 | Poland |
|
Functional and Performance Determinants in Climbers: Examining the Role of Mobility, Stability, and Fatigue Across Proficiency Levels
NCT06830655 · ClinicalTrials.gov ↗ · Fatigue, Joint Hypermobility Syndrome, Climbing Injuries
|
Not applicable | By invitation | 2025-02 | Poland |
|
Comparison Interventions on Kinetic and Kinematic Parameters
NCT07326475 · ClinicalTrials.gov ↗ · Young Football Players, Ankle Sprain Prevention
|
Not applicable | By invitation | 2025-11 | Poland |
|
Assessing the Acute Effects of Diagonal Mobilization
NCT06719752 · ClinicalTrials.gov ↗ · Aged 14 to 16, Play Football Regularly
|
Not applicable | By invitation | 2025-02 | Poland |
|
Ketamine Safety and Tolerability in Psychiatric Inpatient Care (KetGD)
NCT05565352 · ClinicalTrials.gov ↗ · Major Depressive Disorder, Post Traumatic Stress Disorder, Obsessive-Compulsive Disorder
Drug: Ketamine Hydrochloride |
Observational | By invitation | 2022-09 | Poland |
|
Observation of Clozapine Treatment Safety in Bipolar Disorder.
NCT06011460 · Bipolar Disorder
Drug: Clozapine |
Observational | By invitation | 2023-02 | Poland |
|
Application of Elbow Manipulation in Archers
NCT06826300 · ClinicalTrials.gov ↗ · Health
|
Not applicable | By invitation | 2025-02 | Poland |
|
The Effectiveness of an Exercise Program on Scapulohumeral Rhythm, Range of Motion, and Stability in Young Female Handball Players
NCT06875596 · ClinicalTrials.gov ↗ · Scapular Dyskinesis, Handball Players, Female Athlete
|
Not applicable | Active, closed | 2025-03 | Poland |
|
The Study Aims to Investigate the Frequency and Clinical Characteristics of Out-of-hospital Cardiac Arrests (OHCA) Occurring in Poland in 2023. This Research Seeks to Provide a Comprehensive Analysis of OHCA Incidents Across the Country, Focusing on Their Prevalence and the Associated Clinical fe
NCT06948266 · ClinicalTrials.gov ↗ · Cardiac Complications, Sudden Cardiac Arrest, Cardiac Diseases
|
Observational | Active, closed | 2025-01 | Poland |
|
Effect of Time-restricted Eating and Endurance Training on Markers of the Health of Women and Men
NCT05229835 · ClinicalTrials.gov ↗ · Physical Exercise, Time Restricted Eating, Mental Health Wellness 1
|
Not applicable | Active, closed | 2022-01 | Poland |
|
The Effect of Probiotic Supplementation on the Exercise Performance of Long-distance Runners.
NCT07411482 · ClinicalTrials.gov ↗ · Intestinal Microbiome, Probiotic, Runners
|
Not applicable | Active, closed | 2023-12 | Poland |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
Drugs in Medical University of Gdansk trials
14 compoundsDrugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.
Conditions in Medical University of Gdansk trials
84 conditionsBy trial register
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in Poland | 34 | 15 |
| Clinical trials in France | 1 | 1 |
A trial with sites in more than one country appears in each of those registers.
Questions about Medical University of Gdansk trials
How many clinical trials does Medical University of Gdansk sponsor?
Medical University of Gdansk is the lead sponsor of 34 current trials on ClinicalTrials.gov in our Poland and France registers, as of the registry sync on 15 November 2026. Completed and withdrawn studies are not counted.
Are Medical University of Gdansk trials recruiting?
Yes. 15 of its 34 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Which drugs is Medical University of Gdansk testing?
Its current trials name 14 drugs and biologicals as interventions. The most frequent are Apixaban (1), Aspirin (1), Carboplatin (1), Cholecalciferol (1) and Clopidogrel (1). The number in brackets is how many of its trials name each drug.
Where does this information come from?
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
How this page is built
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
- EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 15 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.